Order Article Reprints

Fedele P, Landriscina M, Moraca L, Cusmai A, Gnoni A, Licchetta A, Guarini C, Lanotte L, Pappagallo MN, Melaccio A, et al. Evaluating CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: A Retrospective Real-World Multicenter Study. Cancers. 2024; 16(20):3442. https://doi.org/10.3390/cancers16203442

Fedele, Palma, Matteo Landriscina, Lucia Moraca, Antonio Cusmai, Antonio Gnoni, Antonella Licchetta, Chiara Guarini, Laura Lanotte, Maria Nicla Pappagallo, Assunta Melaccio, and et al. 2024. "Evaluating CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: A Retrospective Real-World Multicenter Study" Cancers 16, no. 20: 3442. https://doi.org/10.3390/cancers16203442

Fedele, P., Landriscina, M., Moraca, L., Cusmai, A., Gnoni, A., Licchetta, A., Guarini, C., Lanotte, L., Pappagallo, M. N., Melaccio, A., Giordano, G., Maselli, F. M., Pinto, A., Giuliani, F., Chiuri, V., Giotta, F., & Gadaleta-Caldarola, G. (2024). Evaluating CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: A Retrospective Real-World Multicenter Study. Cancers, 16(20), 3442. https://doi.org/10.3390/cancers16203442